Urovant Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UROVANT, and when can generic versions of UROVANT drugs launch?
UROVANT has one approved drug.
There are three US patents protecting UROVANT drugs.
There are sixty-nine patent family members on UROVANT drugs in forty-one countries.
Summary for Urovant
| International Patents: | 69 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Urovant
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Urovant | GEMTESA | vibegron | TABLET;ORAL | 213006-001 | Dec 23, 2020 | RX | Yes | Yes | 8,247,415 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Urovant | GEMTESA | vibegron | TABLET;ORAL | 213006-001 | Dec 23, 2020 | RX | Yes | Yes | 8,653,260 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Urovant | GEMTESA | vibegron | TABLET;ORAL | 213006-001 | Dec 23, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Urovant | GEMTESA | vibegron | TABLET;ORAL | 213006-001 | Dec 23, 2020 | RX | Yes | Yes | 12,102,638 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Urovant Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 201992690 | ⤷ Sign Up |
| Singapore | 188883 | ⤷ Sign Up |
| Ecuador | SP10010518 | ⤷ Sign Up |
| Eurasian Patent Organization | 201071169 | ⤷ Sign Up |
| China | 117695287 | ⤷ Sign Up |
| Spain | 2376278 | ⤷ Sign Up |
| South Korea | 20120118086 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
